KPC Pharmaceuticals,Inc. (SHA:600422)
China · Delayed Price · Currency is CNY 8.30
-0.20 (-2.35%)
Jun 9, 2026, 3:00 PM CST
KPC Pharmaceuticals,Inc. Revenue
KPC Pharmaceuticals,Inc. had revenue of 836.16M CNY in the quarter ending March 31, 2026, a decrease of -48.01%. This brings the company's revenue in the last twelve months to 5.80B, down -28.21% year-over-year. In the year 2025, KPC Pharmaceuticals,Inc. had annual revenue of 6.58B, down -21.74%.
Revenue (ttm)
5.80B
Revenue Growth
-28.21%
P/S Ratio
1.08
Revenue / Employee
1.14M
Employees
5,072
Market Cap
6.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.58B | -1.83B | -21.74% |
| Dec 31, 2024 | 8.40B | -28.73M | -0.34% |
| Dec 31, 2023 | 8.43B | 148.11M | 1.79% |
| Dec 31, 2022 | 8.28B | 28.53M | 0.35% |
| Dec 31, 2021 | 8.25B | 536.45M | 6.95% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 7.13B |
| China Animal Husbandry Industry | 6.45B |
| Zhejiang Tianyu Pharmaceutical | 3.11B |
| Guizhou Bailing Group Pharmaceutical | 2.93B |
| Jiuzhitang | 2.40B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.12B |
| Shandong Wit Dyne Health | 2.02B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |